| Announce Date | 11/07/2025 |
| EPS Normalized Actual | $0.05 In Line |
| EPS GAAP Actual | $0.05 In Line |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.04 |
| EPS GAAP Estimate | $0.04 |
| Revenue Estimate | $0.147B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.67 | 6.42 | 0.67 | 0.67 | 1 |
| Dec 2028 | 0.54 | 7.96 | 0.54 | 0.54 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2022 (Nov 2022) | 0.13 | 0.13 | 0.1519B | 100% | 151.9M |
| FQ1 2023 (Mar 2023) | 0 | 0 | 0B | NAN% | 0M |
| FQ2 2023 (Jun 2023) | 0 | 0 | 0B | NAN% | 0M |
| FQ3 2023 (Sep 2023) | 0 | 0 | 0B | -INF% | 0M |
| FQ4 2008 (Nov 2008) | -0.05 | -0.05 | 0.128613B | 100% | 128.61M |
| FQ3 2022 (Aug 2022) | -0.55 | -0.55 | 0.1509B | 100% | 150.9M |
| FQ1 2008 (Mar 2008) | 0.00141585 | 0.00141585 | 0.072089B | 100% | 72.09M |
| FQ1 1999 (Mar 1999) | 0.07 | 0.07 | 0.006B | 100% | 6M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.04
Consensus Revenue Estimates
0.147B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.15 | -- | 0.15 | 0.15 | 1 |
| FQ3 2027 (Sep 2027) | 0.1 | -- | 0.1 | 0.1 | 1 |
| FQ2 2027 (Jun 2027) | 0.12 | -- | 0.12 | 0.12 | 1 |
| FQ1 2027 (Mar 2027) | 0.07 | -- | 0.07 | 0.07 | 1 |
| FQ4 2026 (Dec 2026) | 0.09 | -- | 0.09 | 0.09 | 1 |
| FQ3 2026 (Sep 2026) | 0.065 | -- | 0.065 | 0.065 | 1 |
| FQ2 2026 (Jun 2026) | 0.08 | -- | 0.08 | 0.08 | 1 |
| FQ1 2026 (Mar 2026) | 0.04 | -- | 0.04 | 0.04 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.16B | -- | 0.16B | 0.16B | 1 |
| FQ3 2027 (Sep 2027) | 0.15B | -- | 0.15B | 0.15B | 1 |
| FQ2 2027 (Jun 2027) | 0.15B | -- | 0.15B | 0.15B | 1 |
| FQ1 2027 (Mar 2027) | 0.15B | -- | 0.15B | 0.15B | 1 |
| FQ4 2026 (Dec 2026) | 0.15B | -- | 0.15B | 0.15B | 1 |
| FQ3 2026 (Sep 2026) | 0.15B | -- | 0.15B | 0.15B | 1 |
| FQ2 2026 (Jun 2026) | 0.15B | -- | 0.15B | 0.15B | 1 |
| FQ1 2026 (Mar 2026) | 0.15B | -- | 0.15B | 0.15B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
2
EPS # of in-lines
3
Revenue # of Beats
5
Revenue # of Misses
0
Revenue # of in-lines
3
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2022 (Nov 2022) | 0.13 | 0.13 | 100% | |
| FQ1 2023 (Mar 2023) | 0 | 0 | NAN% | |
| FQ2 2023 (Jun 2023) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
| FQ4 2008 (Nov 2008) | -0.05 | -0.05 | 100% | |
| FQ3 2022 (Aug 2022) | -0.55 | -0.55 | 100% | |
| FQ1 2008 (Mar 2008) | 0.00141585 | 0.00141585 | 100% | |
| FQ1 1999 (Mar 1999) | 0.07 | 0.07 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2022 (Nov 2022) | $0B | $0.15B | $151.9M | 100% |
| FQ1 2023 (Mar 2023) | $0B | $0B | $0M | NAN% |
| FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
| FQ4 2008 (Nov 2008) | $0B | $0.13B | $128.61M | 100% |
| FQ3 2022 (Aug 2022) | $0B | $0.15B | $150.9M | 100% |
| FQ1 2008 (Mar 2008) | $0B | $0.07B | $72.09M | 100% |
| FQ1 1999 (Mar 1999) | $0B | $0.01B | $6M | 100% |